Clinical Trial Update: Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" Phenomenon [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and tolerability of nebicapone in Parkinson disease patients with wearing-off; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Nebicapone (nebicapone)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED